Patents by Inventor Sung-Hyung Lee

Sung-Hyung Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETERODIMERIC ANTIBODIES THAT BIND SOMATOSTATIN RECEPTOR 2
    Publication number: 20180118827
    Abstract: The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind somatostatin receptor 2 (SSTR2)
    Type: Application
    Filed: June 28, 2017
    Publication date: May 3, 2018
    Inventors: Gregory Moore, Rumana Rashid, Sung-Hyung Lee, Paul Foster
  • Heterodimeric antibodies to CD3 X CD123
    Patent number: 9856327
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: January 2, 2018
    Assignee: Xencor, Inc.
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Heterodimeric antibodies to CD3 X CD20
    Patent number: 9850320
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: December 26, 2017
    Assignee: Xencor, Inc.
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • HETERODIMERIC ANTIBODIES TO CD3 X CD123
    Publication number: 20170081420
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: June 17, 2016
    Publication date: March 23, 2017
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • HETERODIMERIC ANTIBODIES TO CD3 X CD123
    Publication number: 20170081424
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: June 17, 2016
    Publication date: March 23, 2017
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
    Publication number: 20160355608
    Abstract: The present invention is directed to novel heterodimeric antibodies.
    Type: Application
    Filed: April 28, 2016
    Publication date: December 8, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal, Sung-Hyung Lee
  • Trispecific antibodies
    Publication number: 20160355600
    Abstract: The invention provides trispecific antibodies that co-engage CD3, CD8 and a tumor target antigen.
    Type: Application
    Filed: December 22, 2015
    Publication date: December 8, 2016
    Inventors: Gregory Moore, John Desjarlais, Seung Chu, Sung-Hyung Lee
  • HETERODIMERIC ANTIBODIES INCLUDING BINDING TO CD8
    Publication number: 20160176969
    Abstract: The invention provides bispecific antibodies that co-engage CD8 (preferably bivalently) and a target tumor antigen.
    Type: Application
    Filed: November 25, 2015
    Publication date: June 23, 2016
    Inventors: Matthew J. Bernett, Gregory Moore, John Desjarlais, Seung Chu, Sung-Hyung Lee